Prevention of immune dysfunction, vitamin E deficiency, and loss of Cryptosporidium resistance during murine retrovirus infection by T cell receptor peptide immunization

Nutrition Research

Volumn 17, Issue 4, 1997, Pages 677-692

  Liang, Bailin ^a   Marchalonis, John J ^b   Watson, Ronald R ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

Cryptosporidium parvum; Cytokine; Immune Dysfunction; Mitogenesis; Murine Retrovirus Infection; NK Cell Activity

Indexed keywords

ALKADIENE; ALPHA TOCOPHEROL; CYTOKINE; GAMMA INTERFERON; HELPER FACTOR; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN LAMBDA CHAIN; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 6; LIPID; PHOSPHOLIPID; T LYMPHOCYTE RECEPTOR; TAU INTERFERON;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALPHA TOCOPHEROL DEFICIENCY; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM PARVUM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNE DEFICIENCY; IMMUNIZATION; INTESTINE VILLUS; INTRAPERITONEAL DRUG ADMINISTRATION; LIPID PEROXIDATION; LYMPH NODE; MITOGENESIS; MOUSE; NATURAL KILLER CELL; NONHUMAN; PHASE CONTRAST MICROSCOPY; PRIORITY JOURNAL; RETROVIRUS INFECTION; SPECTROFLUOROMETRY; SPLEEN CELL;

EID: 0031048988     PISSN: 02715317     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0271-5317(97)00037-7     Document Type: Article

References (47)

1. Watson RR. Minireview of murine models for acquired immune deficiency syndrome. Life Sci 1989; 44: iii-xv.
2. H2 switch is a critical step in the etiology of HIV infection. Immunol Today 1993; 14: 107-111.
3. Sher A, Gazzinelli RT, Oswald IP, Clerici M, et al. Role of T-cell derived cytokines in the downregulation of immune responses in parasitic and retroviral infection. Immunol Rev 1992; 127: 183-204.
4. Gazzinelli RT, Makino M, Chattopadhyay SK, Snapper CM, Sher A, Hugin AW, Morse HC. Preferential activation of Th2 cells during progression of retrovirus-induced immunodeficiency in mice. J Immunol 1992; 148: 182-188.
5. Kanagawa O, Vaupel BA, Gayama S, Koehler G, Kopf M. Resistance of mice deficient in IL-4 to retrovirus-induced immunodeficiency syndrome (MAIDS). Science 1993; 262: 240-242.
6. Fayer R, Ungar BLP. Cryptosporidium spp. and cryptosporidiosis. Microbiol Rev 1986; 50: 458-483.
7. Selik RM, Starcher E, Curran J. Opportunistic diseases in AIDS patients: frequency, association and trends. AIDS 1987; 1: 175-182.
8. Angus KW, Hutchinson G, Campbell I, Snodgrass DB. Prophylactic effects of anti-coccidial drugs in experimental murine cryptosporidiosis. Vet Rec 1984; 114: 166-168.
9. Current WL. The biology of Cryptosporidium. ASM News 1988; 54: 605-611.
10. Soudeyns H, Rebai N, Pantaleo GP, Ciurli C, Boghossian T, Sekaly RP, Fauci AS. The T cell receptor V beta repertoire in HIV-1 infection and disease. Semin Immunol 1993; 5: 175-185.
11. Imberti L, Sottini A, Bettinardi A, Puoti M, Primi D. Selective depletion in HIV infection of T cells that bear specific T cell receptor Vß sequences. Science 1991; 254: 860-862.
12. Watson RR, Wang Y, Dehghanpisheh K, Huang DS, Wood S, Ardestani SK, Liang B, Marchalonis JJ. T cell receptor Vß peptide administration moderates immune dysfunction and cytokine dysregulation induced by murine retrovirus infection. J Immunol 1995; 155: 2282-2291.
13. Marchalonis JJ, Kaymaz H, Dedeoglu F, Schluter SF, Yocum DE, Edmundson AB. Human autoantibodies reactive with synthetic autoantigens from T-cell receptor ß chain. Proc Natl Acad Sci USA 1992; 89: 3325-3329.
14. Toyonaga B, Mak TW. Genes of the T-cell antigen receptor in normal and malignant T-cells. Ann Rev Immunol 1987; 5: 585-620.
15. Feng DF, Doolittle RF. Progressive sequence alignment as a prerequisite to correct phylogenetic trees. J Mol Evol 1987; 25: 351-360.
16. Wang Y, Huang DS, Giger PT, Watson RR. Influence of chronic dietary ethanol on cytokine production by murine splenocytes and thymocytes. Alcohol Clin Exp Res 1994; 18: 64-70.
17. 51Cr-labeled targets for natural killer cytotoxicity assay. J Immunol Methods 1989; 122: 15-24.
18. Arrowood MJ, Sterling CR. Isolation of Cryptosporidium oocysts and sporozoites using discontinuous surcose and isopycnic per cell gradients. J Parasit 1987; 73: 314-319.
19. Darban H, Enriquez J, Sterling CR, Lopez MC, Chen GJ, Abbaszadegan M, Watson RR. Cryptosporidiosis facilitated by murine retroviral infection with LP-BM5. J Inf Dis 1991; 164: 741-745.
20. Tappel AL. Lipid peroxidation damage to cell components. Fed Proceed 1973; 32: 1870-1874.
21. Iverson SA, Cawood P, Madigan MJ, Lawson AM, Dormandy TL. Identification of a diene conjugated component of human lipid as octadeca-9,11 dienoic acid. FEBS Lett 1984; 141: 320-324.
22. Raheja RK, Kaur C, Singh A, Bhatia IS. New colorimetric method for the quantitative estimation of phospholipids without acid digestion. J Lipid Res 1973; 14: 695-697.
23. Burton GW, Webb A, Ingold KU. A mild, rapid, and efficient method of lipid extraction for use in determining vitamin E/lipid ratios. Lipids 1985; 20: 29-39.
24. Howell MD, Winters ST, Olee T, Powell HC, Carlo DJ, Brostoff SW. Vaccination against experimental allergic encephalomyelitis with T cell receptor peptides. Science 1989; 246: 668-670.
25. Dobrescu D, Kabak S, Mehta K, Suh CH, Asch A, Cameron PU, Hotsev AS. Pronett D. N. Human immunodeficiency virus 1 reservoir in CD4+ T cells i srestricted to certain VB subsets. Proc Natl Acad Sci USA 1995; 92: 5563-5567.
26. Chen ZW, Kou ZC, Lekutis C, Shen L, Zhou D, Halloran M, Li J, Sodroski J, Lee-Parritz D, Letvin NL. T cell receptor VB repertoire in an acute infection of rhesus monkeys with simian immunodeficiency viruses and a chimeric simian-human immunodeficiency virus. J Exp Med 1995; 182: 21-31.
27. Marchalonis J J, Lake DF, Schluter SF, Dehghanpisheh K, Watson RR, Ampel NM, Galgiani JN. Autoantibodies against peptide-defined epitopes of T-cell receptors in retrovirally infected humans and mice. Adv Exp Med Biol 1995; 383: 211-222.
28. Victor-Kobrin C, Bonilla FA, Barak A, Bona C. Structural correlates of a regulatory idiotype. Immunol Rev 1989; 110: 151-171.
29. Balkwill FR, Burke F. The cytokine network. Immunol Today 1989; 10: 229-304.
30. Boue F, Wallon C, et al. HTV induced IL-6 production by human B lymphocytes: Role of IL-4. J Immunol 1992; 148: 3761-3787.
31. Van Snick J. Interleukin-6: an overview. Ann Rev Immunol 1990; 8: 253-278.
32. Mellors JW, Griffith BP, Ortiz MA, Landry ML, Ryan JL. Tumor necrosis factor-alpha/cachectin enhances human immunodeficiency virus type 1 replication in primary macrophages. J Infect Dis 1991; 163: 78-82.
33. Poli G, Bressler P, Kinter A, Duh E, Timmer WC, Rabson A, Justement JS, Stanley S, Fauci AS. Interleukin-6 induces human immunodeficiency virus expression in infected monocytic cells alone and in synergy with tumor necrosis factor alpha by transcriptional post-transcriptional mechanisms. J Exp Med 1990; 172: 151-158.
34. Wang JY, Liang B, Watson RR. Vitamin E supplementation with interferon-gamma administration retards immune dysfunction during murine retrovirus infection. J Leuc Biol 1995; 58: 698-703.
35. Whiteside ME, Barkin JS, May RG. Enteric coccidiosis among patients with the acquired immunodeficiency syndrome. Am J Trop Med Hyg 1984; 33: 1065-1072.
36. Soave R. Cryptosporidiosis in AIDS. In:"AIDS and Other Manifestations of HIV Infection" Noyes Publications. 1988; pp. 713-735.
37. Ungar BL, Ward DJ, Fayer R, Quinn CA. Cessation of cryptosporidiosis-associated diarrhea in an acquired imunodeficiency syndrome patient after treatment with hyperimmune bovine colostrum. Gastroenterol 1990; 98: 486-489.
38. Kassa M, Comby E, Lemeteil D, Breasseur P, Ballet JJ. Characterization of anti-Cryptosporidium IgA antibodies in sera from immunocompetent individuals and HIV-infected patients. J Protozool 1991; 38: 179S-180S.
39. Cerny A, Hugin AW, et al. B cells are required for induction of T cell abnormalities in a murine retrovirus-induced immunodeficiency syndrome. J Exp Med 1990; 171: 315-320.
40. + T lymphocytes in protective immunity. J Immunol 1991; 147: 1014-1022.
41. Cerny A, Merino R, Makino M, Waldvogel FA, Morse HC, Izui S. Protective effect of cyclosporin A on immune abnormalities observed in the murine acquired immmmmunodeficiency syndrome. European Journal of Immunology 1991; 21: 1747-1750.
42. Liang B, Lane L, Watson RR. Vitamin E stimulation of disease resistance and immune function. Exp Opin Invest Drugs 1995; 4: 201-211.
43. Favier F, Sappey C, Leclerc P, Faure P, Micoud M. Antioxidant status and lipid peroxidation in patients infected with HIV. Chem Biol Interact 1994; 91: 165-180.
44. Hober D, Haque A, Wattre P, Beaucaire G, Mouton Y, Capron A. Production of tumor necrosis factor-alpha (TNF-α) and interleukin-1 (IL-1) in patients with AIDS. Enhanced level of TNF-α is related to a higher cytotoxic activity. Clin Exp Immunol 1989; 78: 329-333.
45. Chen GJ, Watson RR. Modulation of tumor necrosis factor and gamma interferon production by cocaine and morphine in aging mice infected with LP-BM5, a murine retrovirus. J Leukoc Biol 1991; 50: 349-355.
46. Poli G, Fauci AS. Role of cytokines in the pathogenesis of human immunodeficiency virus infection. In: Human Cytokines: Their Role in Disease and Therapy. (Aggarwal, B.B. and Puri, R.K. Eds.) 1995; pp: 421-450.
47. Wang Y, Huang DS, Liang B, Watson RR. Normalization of nutritional status and immune responses in mice with murine AIDS are normalized by vitamin E supplementation. J Nutr 1994; 124: 2024-2032.